Biogen Idec Raises Guidance, Releases Positive Safety Data On Tysabri
This article was originally published in The Pink Sheet Daily
Executive Summary
After failing to find a buyer, Biogen management assures investors that momentum is on track during the JP Morgan Healthcare Conference.